- Join Us
- About the Event
- About CRI
- Why Immunotherapy
Thanks for visiting our team page.
This year, rather than riding, our whole family will participate in the new Family Run/Walk 5K to raise money for crucial immunotherapy research.
Immunotherapy found early success in the treatment of metastatic melanoma, and Deborah was lucky to have benefited from this type of treatment when she was diagnosed. More than two years after that diagnosis, her lungs remain clear!
To learn more about Deborah's journey, you can read her cancer blog, I'll Live.
We want to make sure crucial research in immunotherapy is funded so that others might benefit.
Please join our team - if you can't join us in person, you can be a virtual team member! - or make a donation to support one of our team members. Remember, 100% of all donations will go to support lifesaving cancer research.
Stephen, diagnosed with metastatic colorectal cancer at 28, enrolled in a clinical trial for a checkpoint inhibitor, a type of immunotherapy.
Read Stephen's Story
Deborah, who was treated with the immunotherapy Yervoy" in combination with radiation for stage III melanoma, participated in the 2016 Answer to Cancer cycling event to raise funds for CRI.
Read Deborah's Story
In 2012, life-long Tennessean Philip was shocked to learn that he had kidney cancer. Not satisfied with the chemotherapy options presented to him, Philip enrolled a clinical trial for the immunotherapy nivolumab (Opdivo").
Read Philip's Story